Literature DB >> 26350633

Three novel presenilin 1 mutations marking the wide spectrum of age at onset and clinical patterns in familial Alzheimer's disease.

Sigrun Roeber1, Felix Müller-Sarnowski2,3, Julia Kress4, Dieter Edbauer3,5, Tanja Kuhlmann6, Frank Tüttelmann7, Christoph Schindler8, Pia Winter4, Thomas Arzberger9,3, Ulrich Müller4, Adrian Danek2,3, Hans A Kretzschmar9.   

Abstract

Presenilin 1 (PSEN1) mutations are the major cause of autosomal dominant Alzheimer's disease (ADAD). Here we report three novel PSEN1 mutations: Ile238_Lys239insIle, Ala246Pro and Ala164Val from patients who manifested in their twenties, forties and seventies, respectively, with variant clinical presentations of dementia. These cases exemplify the tremendous heterogeneity of clinical phenotypes and age of onset associated with PSEN1 mutations. The possibility of ADAD--not previously suspected in two of our patients--should always be considered in neurodegenerative conditions albeit they might neither exhibit the typical clinical picture of Alzheimer's disease nor early onset dementia, which is regarded the primary clinical sign of hereditary neurodegeneration.

Entities:  

Keywords:  Alcoholism; Autosomal dominant Alzheimer’s disease (ADAD); Early onset Alzheimer’s disease (EOAD); PSEN1 mutation; Presenilin; Spastic paraparesis

Mesh:

Substances:

Year:  2015        PMID: 26350633     DOI: 10.1007/s00702-015-1450-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  13 in total

1.  Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.

Authors:  D M Mann; S M Pickering-Brown; A Takeuchi; T Iwatsubo
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

2.  Biological effects of four PSEN1 gene mutations causing Alzheimer disease with spastic paraparesis and cotton wool plaques.

Authors:  Cecile Dumanchin; Isabelle Tournier; Cosette Martin; Mira Didic; Serge Belliard; Bertrand Carlander; François Rouhart; Charles Duyckaerts; Jean-François Pellissier; Jean Baptiste Latouche; Didier Hannequin; Thierry Frebourg; Mario Tosi; Dominique Campion
Journal:  Hum Mutat       Date:  2006-10       Impact factor: 4.878

3.  Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation.

Authors:  John M Ringman; Karen H Gylys; Luis D Medina; Michelle Fox; Vladimir Kepe; Deborah L Flores; Liana G Apostolova; Jorge R Barrio; Gary Small; Daniel H Silverman; Erin Siu; Stephen Cederbaum; Silva Hecimovic; Martina Malnar; Suma Chakraverty; Alison M Goate; Thomas D Bird; James B Leverenz
Journal:  Neurosci Lett       Date:  2010-11-19       Impact factor: 3.046

Review 4.  Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis.

Authors:  Davis C Ryman; Natalia Acosta-Baena; Paul S Aisen; Thomas Bird; Adrian Danek; Nick C Fox; Alison Goate; Peter Frommelt; Bernardino Ghetti; Jessica B S Langbaum; Francisco Lopera; Ralph Martins; Colin L Masters; Richard P Mayeux; Eric McDade; Sonia Moreno; Eric M Reiman; John M Ringman; Steve Salloway; Peter R Schofield; Reisa Sperling; Pierre N Tariot; Chengjie Xiong; John C Morris; Randall J Bateman
Journal:  Neurology       Date:  2014-06-13       Impact factor: 9.910

5.  Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Abeta42 secretion.

Authors:  C De Jonghe; M Cruts; E A Rogaeva; C Tysoe; A Singleton; H Vanderstichele; W Meschino; B Dermaut; I Vanderhoeven; H Backhovens; E Vanmechelen; C M Morris; J Hardy; D C Rubinsztein; P H St George-Hyslop; C Van Broeckhoven
Journal:  Hum Mol Genet       Date:  1999-08       Impact factor: 6.150

6.  A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1.

Authors:  R Crook; A Verkkoniemi; J Perez-Tur; N Mehta; M Baker; H Houlden; M Farrer; M Hutton; S Lincoln; J Hardy; K Gwinn; M Somer; A Paetau; H Kalimo; R Ylikoski; M Pöyhönen; S Kucera; M Haltia
Journal:  Nat Med       Date:  1998-04       Impact factor: 53.440

Review 7.  Pathological and clinical heterogeneity of presenilin 1 gene mutations.

Authors:  Manuel Menéndez
Journal:  J Alzheimers Dis       Date:  2004-10       Impact factor: 4.472

8.  Molecular genetics of Alzheimer's disease: presenilin 1 gene analysis in a cohort of patients from the Poznań region.

Authors:  Anna Kowalska; Mieczyslaw Wender; Jolanta Florczak; Danuta Pruchnik-Wolinska; Renata Modestowicz; Józef Szczech; Grzegorz Rossa; Wojciech Kozubski
Journal:  J Appl Genet       Date:  2003       Impact factor: 3.240

Review 9.  Genetics of dementia.

Authors:  Clement T Loy; Peter R Schofield; Anne M Turner; John B J Kwok
Journal:  Lancet       Date:  2013-08-06       Impact factor: 79.321

10.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.

Authors:  R Sherrington; E I Rogaev; Y Liang; E A Rogaeva; G Levesque; M Ikeda; H Chi; C Lin; G Li; K Holman; T Tsuda; L Mar; J F Foncin; A C Bruni; M P Montesi; S Sorbi; I Rainero; L Pinessi; L Nee; I Chumakov; D Pollen; A Brookes; P Sanseau; R J Polinsky; W Wasco; H A Da Silva; J L Haines; M A Perkicak-Vance; R E Tanzi; A D Roses; P E Fraser; J M Rommens; P H St George-Hyslop
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

View more
  3 in total

1.  Progressive cognitive impairment and familial spastic paraparesis due to PRESENILIN 1 mutation: anatomoclinical characterization.

Authors:  Miren Altuna; Rosa Larumbe; María Victoria Zelaya; Sira Moreno; Virginia García-Solaesa; Maite Mendioroz; María Antonia Ramos; María Elena Erro
Journal:  J Neurol       Date:  2022-04-19       Impact factor: 6.682

Review 2.  Presenilins as Drug Targets for Alzheimer's Disease-Recent Insights from Cell Biology and Electrophysiology as Novel Opportunities in Drug Development.

Authors:  R Scott Duncan; Bob Song; Peter Koulen
Journal:  Int J Mol Sci       Date:  2018-05-31       Impact factor: 5.923

3.  A pathogenic PSEN1 Trp165Cys mutation associated with early-onset Alzheimer's disease.

Authors:  Vo Van Giau; Jung-Min Pyun; Jeewon Suh; Eva Bagyinszky; Seong Soo A An; Sang Yun Kim
Journal:  BMC Neurol       Date:  2019-08-07       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.